Board Meeting7 May 2026, 03:03 pm
Krebs Biochemicals Board Meeting on May 21, 2026
AI Summary
Krebs Biochemicals & Industries Ltd has scheduled a Board of Directors meeting on May 21, 2026, to consider and approve the audited financial results for the fourth quarter and financial year ended March 31, 2026. The trading window for insiders has been closed since March 31, 2026, and will remain closed until 48 hours after the declaration of the results.
Key Highlights
- Board meeting scheduled for May 21, 2026, to approve audited financial results.
- Meeting pertains to Q4 and FY26 results ending March 31, 2026.
- Trading window closed for insiders until 48 hours post result declaration.
Price Impact
More from KREBSBIO